Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Sionna Therapeutics, Inc.NASDAQ: SION
Net Debt · Q1 FY2026 · quarter ended Mar 2026
Net debt remains negative
Q1 FY2026 net debt was -$54.95M, compared with -$73.2M a year earlier.
Context
- Net debt amounted to 18.0% of total assets at the end of Q1 FY2026, down 1.8 pp from a year earlier.
- Net debt grew in size in 1 of the last 3 fiscal years.
What to watch
Whether net debt keeps rising in the next quarterly balance sheet after a +24.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- (49.77M) USD
- Year-over-year change
- -77.5%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (49.77M) | -77.5% |
| FY2024 | 2024-12-31 | (28.04M) | +0.0% |
| FY2023 | 2023-12-31 | (28.04M) | +48.9% |
| FY2022 | 2022-12-31 | (54.84M) | — |
Net Debt vs competitors
How SION compares with its peers on the latest reported figures
- SION's Mar 2026 net debt of -$54.95M is the 8th highest of the 11 companies compared; the peer median is -$23.53M.
- Its year-over-year change of +24.9% is the 6th highest of 11, against a peer median of +32.7%.
- Net debt amounts to 18.0% of total assets for SION, versus a peer median of 17.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $562.25M | +1324.1% | — | 47.8% | |
| Mar 2026 | $177.06M | +42.4% | — | 35.1% | |
| Jun 2026 | $59M | -53.1% | — | 15.9% | |
| Jun 2026 | $26.35M | -7.3% | — | 4.9% | |
| Sep 2026 | -$17.08M | +48.9% | — | 2.4% | |
| Sep 2026 | -$29.98M | -150.8% | — | 2.0% | |
| Mar 2026 | -$30.26M | +40.8% | — | 2.9% | |
| Mar 2026 | -$54.95M | +24.9% | — | 18.0% | |
| Mar 2026 | -$74.42M | -135.4% | — | 19.0% | |
| Mar 2026 | -$137.54M | +48.8% | — | 32.8% | |
| Sep 2026 | -$202.58M | +24.6% | — | 40.1% | |
| Peer median (excluding SION) | -$23.53M | +32.7% | — | 17.4% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.